Market footprint United Allergy Services operates across 20 states with a network of over 2,450 practitioners and has delivered treatment to more than 350,000 patients, indicating a scalable platform for expanding partnerships and cross-referrals in new regions.

Immunotherapy leader The company positions itself around immunotherapy as a disease-modifying treatment for allergies, suggesting upsell opportunities with primary care and specialists to adopt expanded IT-based care pathways and testing services.

Growth leadership Recent leadership move bringing on a Vice President of Strategic Growth signals emphasis on strategic expansion and partner acquisition, aligning with business development efforts to identify new practice groups and health systems as targets.

Clinical partnerships With CAT/CAS staff providing testing and customized treatments under provider supervision, there is a potential to license or co-develop turnkey testing and IT protocols for broader provider networks and ambulatory care settings.

Financial opportunity Revenue range and modest funding indicate a mid-market growth profile; there may be opportunities to offer scalable services, technology integrations, and support contracts to similar-sized clinics or regional health networks seeking allergy program expansion.